Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome

Open access
Zhang, Lei, Ye, Chen, Li, Peng, Li, Chuanding, Shu, Weigang, Zhao, Yujie, Wang, Xiaolei · 2022 · Stem Cell Research & Therapy

Abstract

Background: Adipose-derived stem cells (ADSCs) have provided promising applications for Crohn’s disease (CD). However, the practical efficacy of ADSCs remains controversial, and their mechanism is still unclear. Based on the pathogenesis of dysregulated immune responses and abnormal lymphatic alterations in CD, vascular endothelial growth factor-C (VEGF-C) is thought to be a favourable growth factor to optimize ADSCs. We aimed to investigate the efficacy of VEGF-C-stimulated ADSCs and their dual mechanisms in both inhibiting inflammation “IN” and promoting inflammation “OUT” in the intestine. Methods: Human stem cells isolated from adipose tissues were identified, pretreated with or without 100 ng/ml VEGF-C and analysed for the secretion of cell culture supernatants in vitro. Lymphatic endothelial cells (LECs) were treated with ADSCs-conditioned medium or co-cultured with ADSCs and VEGF-C stimulated ADSCs. Changes in LECs transmigration, and VEGF-C/VEGFR-3 mRNA levels were assessed by transwell chamber assay and qRT–PCR. ADSCs and VEGF-C-stimulated ADSCs were intraperitoneally injected into mice with TNBS-induced chronic colitis. ADSCs homing and lymphatic vessel density (LVD) were evaluated by immunofluorescence staining. Lymphatic drainage was assessed using Evans blue. Cytokines and growth factors expression was detected respectively by ELISA and qRT–PCR. The protein levels of VEGF-C/VEGFR-3-mediated downstream signals and the NF-κ B pathway were assayed by western blot. Faecal microbiota was measured by 16S rRNA sequencing. Results: ADSCs stimulated with VEGF-C released higher levels of growth factors (VEGF-C, TGF-β1, and FGF-2) and lower expression of cytokines (IFN-γ and IL-6) in cell supernatants than ADSCs in vitro (all P < 0.05). Secretome released by VEGF-C stimulated ADSCs exhibited a stronger LEC migratory capability and led to elevated VEGF-C/VEGFR-3 expression, but these effects were markedly attenuated by VEGFR-3 inhibitor. VEGF-C-stimulated ADSCs homing to the inflamed colon and mesenteric lymph nodes (MLNs) can exert stronger efficacy in improving colitis symptoms, reducing inflammatory cell infiltration, and significantly enhancing lymphatic drainage. The mRNA levels and protein concentrations of anti-inflammatory cytokines and growth factors were markedly increased with decreased proinflammatory cytokines in the mice treated with VEGF-C-stimulated ADSCs. Systemic administration of VEGF-C-stimulated ADSCs upregulated the colonic VEGF-C/VEGFR-3 pathway and activated downstream AKT and ERK phosphorylation signalling, accompanied by decreased NF-κ B p65 expression. A higher abundance of faecal p-Bacteroidetes and lower p-Firmicutes were detected in mice treated with VEGF-C-stimulated ADSCs (all P < 0.05). Conclusion: VEGF-C-stimulated ADSCs improve chronic intestinal inflammation by promoting lymphatic drainage and enhancing paracrine signalling via activation of VEGF-C/VEGFR-3-mediated signalling and inhibition of the NF-κ B pathway. Our study may provide a new insight into optimizing ADSCs treatment and investigating potential mechanisms in CD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13287-022-03132-3

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic drawing of colitis establishment, intervention and evaluation in TNBS-induced chronic colitis. Female BALB/c mice at 4–5 weeks of age (N = 9 per group) were infused with TNBS into their colons 5 times, and ADSCs and VEGF-C-stimulated ADSCs (1 × 106/0.2 ml) were injected intraperitoneally on Day 8 and Day 36
Fig. 1 Schematic drawing of colitis establishment, intervention and evaluation in TNBS-induced chronic colitis. Female BALB/c mice at 4–5 weeks of age (N = 9 per group) were infused with TNBS into their colons 5 times, and ADSCs and VEGF-C-stimulated ADSCs (1 × 106/0.2 ml) were injected intraperitoneally on Day 8 and Day 36CC BY · PubMed Central
Fig. 2 Characterization and identification of isolated ADSCs and VEGF-C stimulated ADSCs in vitro and homing of ADSCs in vivo. a Images of ADSCs in the primary passage on Day 1 and Day 3. Scale bar 100 μm; ×100, magnification. b, c Flow cytometry analysis of surface immunophenotype in the ADSCs and VEGF-C pretreated ADSCs, respectively. The blue line represents blank control and the red line represents marked ADSCs. d Detection of the multipotent capacity of ADSCs to induce adipogenic and osteogenic differentiation by Oil Red O and Alizarin Red staining, respectively. Scale bar 100 μm; × 200, magnification. e Images of ADSCs unstimulated and stimulated with VEGF-C at the 5th passage. Scale bar 100 μm; × 100, magnification. f The distribution of the injected PKH67-labelled ADSCs (green) in the murine colon under a fluorescence microscope with DAPI (blue). Scale bar 100 μm; × 200, magnification
Fig. 2 Characterization and identification of isolated ADSCs and VEGF-C stimulated ADSCs in vitro and homing of ADSCs in vivo. a Images of ADSCs in the primary passage on Day 1 and Day 3. Scale bar 100 μm; ×100, magnification. b, c Flow cytometry analysis of surface immunophenotype in the ADSCs and VEGF-C pretreated ADSCs, respectively. The blue line represents blank control and the red line represents marked ADSCs. d Detection of the multipotent capacity of ADSCs to induce adipogenic and osteogenic differentiation by Oil Red O and Alizarin Red staining, respectively. Scale bar 100 μm; × 200, magnification. e Images of ADSCs unstimulated and stimulated with VEGF-C at the 5th passage. Scale bar 100 μm; × 100, magnification. f The distribution of the injected PKH67-labelled ADSCs (green) in the murine colon under a fluorescence microscope with DAPI (blue). Scale bar 100 μm; × 200, magnificationCC BY · PubMed Central
Fig. 3 Secretome in the supernatants of ADSCs stimulated with or without VEGF-C in vitro and their effects of LECs migration, VEGF-C/VEGFR-3 expression. a Concentrations of proinflammatory cytokines (IFN-γ, IL-6) and anti-inflammatory cytokines (IL-10) in cell culture supernatants were detected by ELISA. b Concentrations of growth factors (VEGF-C, TGF-β1, IGF-1, FGF-2) in cell culture supernatants detected by ELISA. (N = 4, *P < 0.05, **P < 0.01) c Representative images of LEC migration per group were captured at 12 h. Scale bar 100 μm; × 100, magnifications. d Quantification of transwell migration assay data. e Relative mRNA expression levels of VEGF-C. f Relative mRNA expression levels of VEGFR-3. (N = 3, *P < 0.05, **P < 0.01). ELISA results are shown as the means ± standard deviation (SD) while migration count and mRNA data are presented as the means ± standard errors (SEM)
Fig. 3 Secretome in the supernatants of ADSCs stimulated with or without VEGF-C in vitro and their effects of LECs migration, VEGF-C/VEGFR-3 expression. a Concentrations of proinflammatory cytokines (IFN-γ, IL-6) and anti-inflammatory cytokines (IL-10) in cell culture supernatants were detected by ELISA. b Concentrations of growth factors (VEGF-C, TGF-β1, IGF-1, FGF-2) in cell culture supernatants detected by ELISA. (N = 4, *P < 0.05, **P < 0.01) c Representative images of LEC migration per group were captured at 12 h. Scale bar 100 μm; × 100, magnifications. d Quantification of transwell migration assay data. e Relative mRNA expression levels of VEGF-C. f Relative mRNA expression levels of VEGFR-3. (N = 3, *P < 0.05, **P < 0.01). ELISA results are shown as the means ± standard deviation (SD) while migration count and mRNA data are presented as the means ± standard errors (SEM)CC BY · PubMed Central
Fig. 4 The therapeutic effects of VEGF-C-stimulated ADSCs on TNBS-induced colitis. a Survival rate. N = 9 mice per group. b Colitis score. c DAI based on body weight changes, stool traits, and haematochezia. d Weight changes. e Representative images of colon length per group. f Comparison of colon length. g Representative images of colon macroscopic damage per group. h Representative images of mucosal lesions per group. i Macroscopic damage score. j Representative images of representative H&E staining images per group. Scale bar 100 μm; ×200, magnifications. k Histological score. l Representative Masson’s trichrome-stained image per group. Scale bar 100 μm; ×200, magnifications. m Collagen deposition was quantified as a ratio of the positive area to the total area of colon tissues. (N ≥ 5, *P < 0.05, **P < 0.01)
Fig. 4 The therapeutic effects of VEGF-C-stimulated ADSCs on TNBS-induced colitis. a Survival rate. N = 9 mice per group. b Colitis score. c DAI based on body weight changes, stool traits, and haematochezia. d Weight changes. e Representative images of colon length per group. f Comparison of colon length. g Representative images of colon macroscopic damage per group. h Representative images of mucosal lesions per group. i Macroscopic damage score. j Representative images of representative H&E staining images per group. Scale bar 100 μm; ×200, magnifications. k Histological score. l Representative Masson’s trichrome-stained image per group. Scale bar 100 μm; ×200, magnifications. m Collagen deposition was quantified as a ratio of the positive area to the total area of colon tissues. (N ≥ 5, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 5 Evaluating colonic formation of lymphatic vessels and lymphatic drainage. a Immunofluorescence staining of LYVE-1+ lymphatic vessels and CD31.+ blood vessels. Scale bar 50 μm; ×200, magnification. b Lymphatic vessel density. c Microvascular density. d Residual Evans blue dye of the terminal colon. e Analysis of lymphatic drainage with rectal submucosal injection of Evans blue dye. (N ≥ 4, *P < 0.05, **P < 0.01)
Fig. 5 Evaluating colonic formation of lymphatic vessels and lymphatic drainage. a Immunofluorescence staining of LYVE-1+ lymphatic vessels and CD31.+ blood vessels. Scale bar 50 μm; ×200, magnification. b Lymphatic vessel density. c Microvascular density. d Residual Evans blue dye of the terminal colon. e Analysis of lymphatic drainage with rectal submucosal injection of Evans blue dye. (N ≥ 4, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 6 VEGF-C pretreatment helped build up pro- and anti-inflammatory balance via the increment of growth factors. The relative mRNA expression levels of a IFN-γ, b IL-6, c IL-10, d TGF-β1, e FGF-2, f IGF-1, g VEGF-C and h VEGFR-3 in the colons. The protein concentrations of i IFN-γ, j IL-6, k IL-10, l FGF-2, m IGF-1 and n VEGF-C. mRNA data are presented as the means ± standard errors (SEM) while ELISA results are shown as the means ± standard deviation (SD) (N = 4, *P < 0.05, **P < 0.01)
Fig. 6 VEGF-C pretreatment helped build up pro- and anti-inflammatory balance via the increment of growth factors. The relative mRNA expression levels of a IFN-γ, b IL-6, c IL-10, d TGF-β1, e FGF-2, f IGF-1, g VEGF-C and h VEGFR-3 in the colons. The protein concentrations of i IFN-γ, j IL-6, k IL-10, l FGF-2, m IGF-1 and n VEGF-C. mRNA data are presented as the means ± standard errors (SEM) while ELISA results are shown as the means ± standard deviation (SD) (N = 4, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 7 VEGF-C-stimulated ADSCs activated a VEGF-C/VEGFR-3-dependent mechanism and suppressed the NF-κB pathway in chronic experimental colitis. a The protein bands of VEGF-C and VEGFR-3. b Quantification of VEGF-C relative to GAPDH. c Quantification of VEGFR-3 relative to GAPDH. d The protein bands of AKT, p-AKT, ERK1/2 and p-ERK1/2. e Quantification of p-AKT relative to AKT. f Quantification of p-ERK1/2 relative to ERK1/2. g The protein bands of IκBα, p-IκBα, NF-κB p65 and p-NF-κB p65. h Quantification of p-IκBα relative to IκBα. i Quantification of p-NF-κB p65 relative to NF-κB p65. (N = 4, *P < 0.05, **P < 0.01)
Fig. 7 VEGF-C-stimulated ADSCs activated a VEGF-C/VEGFR-3-dependent mechanism and suppressed the NF-κB pathway in chronic experimental colitis. a The protein bands of VEGF-C and VEGFR-3. b Quantification of VEGF-C relative to GAPDH. c Quantification of VEGFR-3 relative to GAPDH. d The protein bands of AKT, p-AKT, ERK1/2 and p-ERK1/2. e Quantification of p-AKT relative to AKT. f Quantification of p-ERK1/2 relative to ERK1/2. g The protein bands of IκBα, p-IκBα, NF-κB p65 and p-NF-κB p65. h Quantification of p-IκBα relative to IκBα. i Quantification of p-NF-κB p65 relative to NF-κB p65. (N = 4, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 8 Immunomodulatory functions of ADSCs and VEGF-C + ADSCs on immune cells in the colon and MLNs. a CD4+ T cells and CD8+ T cells in the colon tissues were observed by IHC. ×200, magnification. b CD11c+ dendritic cells in the colon tissues were observed by IF. ×200, magnification. c Colonic CD4+ T cells. d Colonic CD8+ T cells. e Colonic CD11c+ dendritic cells. All immune cells were counted per field (N = 5) using ImageJ. (N = 3, *P < 0.05, **P < 0.01)
Fig. 8 Immunomodulatory functions of ADSCs and VEGF-C + ADSCs on immune cells in the colon and MLNs. a CD4+ T cells and CD8+ T cells in the colon tissues were observed by IHC. ×200, magnification. b CD11c+ dendritic cells in the colon tissues were observed by IF. ×200, magnification. c Colonic CD4+ T cells. d Colonic CD8+ T cells. e Colonic CD11c+ dendritic cells. All immune cells were counted per field (N = 5) using ImageJ. (N = 3, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 9 Diversity and abundance analysis of the faecal microbiota of TNBS-induced colitis mice after treatment. a Taxonomic profiling revealed differences at the phylum level. Each column displayed an individual mouse and the top 20 most abundant bacteria. b Taxonomic profiling revealed differences at the genus level. Each column displayed an individual mouse and the top 20 most abundant bacteria. c Taxonomic cladogram obtained from LEfSe analysis. d Linear discriminant analysis (LDA) score for different taxa abundances. (N = 3, *P < 0.05, **P < 0.01)
Fig. 9 Diversity and abundance analysis of the faecal microbiota of TNBS-induced colitis mice after treatment. a Taxonomic profiling revealed differences at the phylum level. Each column displayed an individual mouse and the top 20 most abundant bacteria. b Taxonomic profiling revealed differences at the genus level. Each column displayed an individual mouse and the top 20 most abundant bacteria. c Taxonomic cladogram obtained from LEfSe analysis. d Linear discriminant analysis (LDA) score for different taxa abundances. (N = 3, *P < 0.05, **P < 0.01)CC BY · PubMed Central
Fig. 10 Schematic depiction of the underlying mechanisms by which VEGF-C-stimulated ADSCs alleviate chronic colitis via lymphangiogenesis and immunomodulatory effects. VEGF-C-stimulated ADSCs could simultaneously improve lymphatic drainage (“OUT”) and inhibit the inflammatory response (“IN”) by activating VEGF-C/VEGFR-3-dependent signals and suppressing the NF-κB pathway
Fig. 10 Schematic depiction of the underlying mechanisms by which VEGF-C-stimulated ADSCs alleviate chronic colitis via lymphangiogenesis and immunomodulatory effects. VEGF-C-stimulated ADSCs could simultaneously improve lymphatic drainage (“OUT”) and inhibit the inflammatory response (“IN”) by activating VEGF-C/VEGFR-3-dependent signals and suppressing the NF-κB pathwayCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 38

Metadata

Authors
Zhang, L., Ye, C., Li, P., Li, C., Shu, W., Zhao, Y., & Wang, X.
Affiliations
  • Tongji University (CN)
  • Soochow University (CN)
  • ShanghaiTech University (CN)
Corresponding author
  • Zhao, Yujie
  • Wang, Xiaolei
Venue
Stem Cell Research & Therapy
Published
2022-09-05
Volume
13
Issue
1
Pages
448-448
ISSN
1757-6512 (ISSN-L)
OpenAlex
W4294610460
Cited by
38
References
67
Citations by year
2026: 6 · 2025: 14 · 2024: 12 · 2023: 6
FWCI
4.83
Type
journal article
Language
en
Open access
Licence
Locations
  • Stem Cell Research & Therapy (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China (81670476, 81970449)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
adipose-derived stem cells, VEGF-C, VEGFR-3, lymphatic drainage, lymphatic endothelial cells, NF-κB signaling, Crohn's disease, intestinal inflammation, stem cell secretome, TNBS-induced colitis, stem cell homing, lymphatic vessel density, gut microbiota, TGF-β1, FGF2, interferon-gamma
MeSH terms
Secretome, Animals, Colitis, Humans, Inflammation, RNA, Messenger, RNA, Ribosomal, 16S, Stem Cells, Cytokines, NF-kappa B, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor Receptor-3, Vascular Endothelial Growth Factor C, Endothelial Cells, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome. https://app.cochat.ai/papers/10.1186/s13287-022-03132-3
The paper
Zhang, L., Ye, C., Li, P., Li, C., Shu, W., Zhao, Y., & Wang, X. (2022). ADSCs stimulated by VEGF-C alleviate intestinal inflammation via dual mechanisms of enhancing lymphatic drainage by a VEGF-C/VEGFR-3-dependent mechanism and inhibiting the NF-κB pathway by the secretome. Stem Cell Research & Therapy. https://doi.org/10.1186/s13287-022-03132-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.